These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10645404)

  • 1. The detection of unknown primary tumors in patients with cervical metastases by dual-head positron emission tomography.
    Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
    Oral Oncol; 1999 Jul; 35(4):390-4. PubMed ID: 10645404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: a pilot study.
    Stokkel MP; ten Broek FW; van Rijk PP
    Eur J Nucl Med; 1999 May; 26(5):499-503. PubMed ID: 10382094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation.
    Jungehülsing M; Scheidhauer K; Damm M; Pietrzyk U; Eckel H; Schicha H; Stennert E
    Otolaryngol Head Neck Surg; 2000 Sep; 123(3):294-301. PubMed ID: 10964310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
    Regelink G; Brouwer J; de Bree R; Pruim J; van der Laan BF; Vaalburg W; Hoekstra OS; Comans EF; Vissink A; Leemans CR; Roodenburg JL
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.
    Greven KM; Keyes JW; Williams DW; McGuirt WF; Joyce WT
    Cancer; 1999 Jul; 86(1):114-8. PubMed ID: 10391570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer.
    Pai M; Park CH; Suh JH; Koh JH
    Clin Nucl Med; 1999 Jul; 24(7):495-500. PubMed ID: 10402001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of unknown primary head and neck tumors by positron emission tomography.
    Braams JW; Pruim J; Kole AC; Nikkels PG; Vaalburg W; Vermey A; Roodenburg JL
    Int J Oral Maxillofac Surg; 1997 Apr; 26(2):112-5. PubMed ID: 9151165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors.
    AAssar OS; Fischbein NJ; Caputo GR; Kaplan MJ; Price DC; Singer MI; Dillon WP; Hawkins RA
    Radiology; 1999 Jan; 210(1):177-81. PubMed ID: 9885604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of diffusion-weighted imaging and
    Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study.
    Johansen J; Eigtved A; Buchwald C; Theilgaard SA; Hansen HS
    Laryngoscope; 2002 Nov; 112(11):2009-14. PubMed ID: 12439171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG PET detection of unknown primary tumors.
    Bohuslavizki KH; Klutmann S; Kröger S; Sonnemann U; Buchert R; Werner JA; Mester J; Clausen M
    J Nucl Med; 2000 May; 41(5):816-22. PubMed ID: 10809197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary.
    Freudenberg LS; Fischer M; Antoch G; Jentzen W; Gutzeit A; Rosenbaum SJ; Bockisch A; Egelhof T
    Med Princ Pract; 2005; 14(3):155-60. PubMed ID: 15863988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of positron emission tomography in occult primary head and neck cancers.
    Safa AA; Tran LM; Rege S; Brown CV; Mandelkern MA; Wang MB; Sadeghi A; Juillard G
    Cancer J Sci Am; 1999; 5(4):214-8. PubMed ID: 10439166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of FDG PET on the management of occult primary head and neck tumours.
    Wong WL; Saunders M
    Clin Oncol (R Coll Radiol); 2003 Dec; 15(8):461-6. PubMed ID: 14690001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome.
    Dale E; Moan JM; Osnes TA; Bogsrud TV
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1015-1019. PubMed ID: 27671150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission imaging of head and neck cancer, including thyroid carcinoma.
    Schöder H; Yeung HW
    Semin Nucl Med; 2004 Jul; 34(3):180-97. PubMed ID: 15202100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unknown primary detected by FDG-PET. A review of the present indications of FDG-PET in head and neck cancers.
    Sheikholeslam-zadeh R; Choufani G; Goldman S; Hassid S
    Acta Otorhinolaryngol Belg; 2002; 56(1):77-82. PubMed ID: 11894635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography.
    Stoeckli SJ; Mosna-Firlejczyk K; Goerres GW
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):411-6. PubMed ID: 12634970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor.
    Fogarty GB; Peters LJ; Stewart J; Scott C; Rischin D; Hicks RJ
    Head Neck; 2003 Feb; 25(2):138-45. PubMed ID: 12509797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a coincidence gamma camera to detect primary tumor with 18fluoro-2-deoxy-glucose in cervical lymph node metastases from an unknown origin.
    Périé S; Talbot JN; Monceaux G; Grahek D; Kerrou K; Montravers F; St Guily JL
    Ann Otol Rhinol Laryngol; 2000 Aug; 109(8 Pt 1):755-60. PubMed ID: 10961809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.